Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
GPCR Therapeutics, Inc.
GPCR Therapeutics, Inc.
Thomas Jefferson University
University of Chicago
Washington University School of Medicine
City of Hope Medical Center
M.D. Anderson Cancer Center
Insel Gruppe AG, University Hospital Bern
University of Liverpool
University of Illinois at Chicago
University of Nebraska
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Virginia Commonwealth University
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
University of Kansas Medical Center
Barbara Ann Karmanos Cancer Institute
GPCR Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sanofi
Dartmouth-Hitchcock Medical Center
Pfizer
Array BioPharma
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Columbia University
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
City of Hope Medical Center
Maria Sklodowska-Curie National Research Institute of Oncology
Stanford University
Washington University School of Medicine
Stanford University
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Stanford University
OHSU Knight Cancer Institute
University of Florida
Washington University School of Medicine
University of Washington
Beth Israel Deaconess Medical Center
University of Kansas Medical Center
SWOG Cancer Research Network
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Mayo Clinic